financetom
Business
financetom
/
Business
/
JSPL bets on positive steel outlook, demand; targets 8.25 million tonne volume in FY22
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JSPL bets on positive steel outlook, demand; targets 8.25 million tonne volume in FY22
Sep 1, 2021 3:39 AM

The steel outlook is quite positive, said VR Sharma, MD of Jindal Steel and Power Ltd (JSPL), in an interview to CNBC-TV18.

Share Market Live

NSE

The correction in long product prices happened last month for about Rs 2,000 per tonne and was regained by Rs 500-700 per tonne.

Assessing the steel demand, he said, “While the demand as well as prices are quite strong on flat products, some pressure can be seen on long products.”

Also Read:

JSPL aims to reduce debt below Rs 10,000 crore by FY22-end

In terms of private capex and government orders, he said, “80 percent demand is from government-related infra projects be it rails, roads, bridges, buildings, housing, water connectivity pipelines. These projects will take about 6-8 months.”

According to him, overall demand is going to be very bullish.

The company has given a volume target of 8.25 million tonne for FY22. “We will be crossing 8.25 million tonne. The flat products are doing extremely well. Hot-rolled coils as well as plates are doing extremely well. So in general, I would say that there will be a positive outlook on all,” he shared.

“Blended realisations came down to Rs 2,000 per tonne and regained Rs 1,000 per tonne, so there is a net redemption loss of Rs 1,000 per tonne over the month of June,” Sharma said.

Also Read: Auto demand patchy across segments, don’t expect huge discounts this festive season: CRISIL

“Whatever reduction in iron ore prices will take place will be passed on to customers,” he said.

While giving the guidance on EBITDA per tonne, he mentioned that the company will be in a position to maintain the EBITDA margin.

The company has announced a Jindal Power Ltd (JPL) deal, which will be unlocking value for shareholders. When asked when the deal will get completed, he said, “The statutory provisions are required from the Indian government and I think this may take three to four months - by the end of this calendar year, we are expecting that this deal will mature.”

For the full interview, what the accompanying video.

Catch all live market action here.

(Edited by : Dipika Ghosh)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Spreedly Acquires Dodgeball to Link Payment Optimization with Fraud Prevention
Spreedly Acquires Dodgeball to Link Payment Optimization with Fraud Prevention
Sep 17, 2025
The acquisition advances Spreedly's strategy to seamlessly integrate payment optimization and fraud management within a unified open payments platform DURHAM, N.C., Sept. 17, 2025 /PRNewswire/ -- Spreedly (www.spreedly.com), a leading open payments platform, today announced its acquisition of Dodgeball, a modern fraud orchestration company. The acquisition brings payments optimization and fraud management under one platform, while advancing Spreedly's artificial intelligence and open payments...
Nike Showing Signs of Recovery With Order Book, Gross Margins in Focus, BofA Says
Nike Showing Signs of Recovery With Order Book, Gross Margins in Focus, BofA Says
Sep 17, 2025
11:31 AM EDT, 09/17/2025 (MT Newswires) -- Nike ( NKE ) is showing signs of recovery as wholesale order books improve and channel inventories appear on track to be clean by mid-year, which would support a return to growth in H2, BofA Securities said in a Wednesday note. The firm expects a modest Q1 upside and models EPS of $0.28...
Johnson & Johnson's Icotrokinra Meets Co-Primary Endpoints in Phase 3 Plaque Psoriasis Trials
Johnson & Johnson's Icotrokinra Meets Co-Primary Endpoints in Phase 3 Plaque Psoriasis Trials
Sep 17, 2025
11:36 AM EDT, 09/17/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Wednesday its psoriasis drug candidate icotrokinra met both co-primary endpoints in the phase 3 Iconic-Advance 1 and 2 studies. Icotrokinra showed superior skin clearance compared to placebo at week 16 and deucravacitinib at both weeks 16 and 24. The treatment demonstrated similar adverse event rates when...
Deutsche Bank backs proposed global defence bank
Deutsche Bank backs proposed global defence bank
Sep 17, 2025
BERLIN/LONDON, Sept 17 (Reuters) - Deutsche Bank supports the establishment of the Defence, Security and Resilience Bank (DSRB), an initiative to create a global state-backed defence bank to fund countries' rearmament, it said on Wednesday. Deutsche Bank has joined rivals already signed up including JPMorgan ( JPM ) and Commerzbank in assisting the proposed multilateral lender, according to the DSRB's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved